Nyxoah S.A. (NYXH)
NASDAQ: NYXH · IEX Real-Time Price · USD
7.02
-0.08 (-1.13%)
At close: Jul 2, 2024, 3:53 PM
7.00
-0.02 (-0.28%)
After-hours: Jul 2, 2024, 4:34 PM EDT
Nyxoah Market Cap
Nyxoah has a market cap or net worth of $241.21 million as of July 2, 2024. Its market cap has increased by 7.11% in one year.
Market Cap
241.21M
Enterprise Value
207.29M
1-Year Change
7.11%
Ranking
Category
Stock Price
$7.02
Market Cap Chart
Since the IPO on July 2, 2021, Nyxoah's market cap has decreased from $746.03M to $241.21M, a decrease of -67.67%. That is a compound annual growth rate of -31.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 201.60M | 51.58% |
| Dec 29, 2023 | 133.00M | 3.42% |
| Dec 30, 2022 | 128.60M | -77.52% |
| Dec 31, 2021 | 572.00M | -23.33% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tectonic Therapeutic | 242.67M |
| AngioDynamics | 242.33M |
| Auna SA | 240.00M |
| Molecular Partners AG | 239.91M |
| Sutro Biopharma | 239.66M |
| CorMedix | 237.97M |
| Aquestive Therapeutics | 236.70M |
| Utah Medical Products | 235.73M |